Benign prostate hyperplasia. Hyperplasia of prostate
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: The classical indications for prostate surgery Patients with prostate size between 30 and 70 grams Complete the informed consent form by the patient
Exclusion criteria
Exclusion criteria: Previous prostate surgery with high PSA (Prostate Specific Antigen) Levels Uncontrolled diabetes History of CVA (cerebral vascular accident) and neurological diseases Urinary tract obstruction Addiction Use of neurological and anticholinergic drugs
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Benign prostatic hyperplasia. Timepoint: One week after surgery, then one month, 3 months and 6 months after surgery. Method of measurement: The amount of Q-Max (Maximum urinary flow) in the uroflowmetry before and after the surgery. | — |
Secondary
| Measure | Time frame |
|---|---|
| Bleeding. Timepoint: During surgery, up to a week later. Method of measurement: The rate of receiving blood during and after surgery, and expert examination.;Wound infection. Timepoint: One week after surgery, then up to 1 month after surgery. Method of measurement: Expert examination.;Duration of catheterization after surgery. Timepoint: 1,3,7 days after surgery. Method of measurement: Expert examination.;Urethral stricture. Timepoint: 1 week, 1 month and 3 months after surgery. Method of measurement: Expert examination and retrograde urethrography. | — |
Countries
Iran (Islamic Republic of)
Contacts
Yazd University of Medical Sciences